Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production Medical Dialogues Bureau14 April 2020 9:22 AMThe raw materials which earlier used to cost Rs 9,000 per kilogram are now being sold at Rs 55,000-75,000
Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD Medical Dialogues Bureau14 April 2020 8:15 AMMumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial...
Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance Medical Dialogues Bureau13 April 2020 10:18 AMCompanies like Zydus Cadila and IPCA are the major manufacturers of hydroxychloroquine in the country, Jain said
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries Medical Dialogues Bureau11 April 2020 4:00 AMParis: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT Medical Dialogues Bureau9 April 2020 4:30 AMNew York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
Coronavirus: India to export hydroxychloroquine on case-by-case basis; Rahul Gandhi says ensure Indians get it first Medical Dialogues Bureau8 April 2020 3:30 AMHydroxychloroquine is an old and inexpensive drug used to treat malaria.
Govt tightens export ban norms for anti-malarial drug hydroxychloroquine Medical Dialogues Bureau6 April 2020 4:30 AMNew Delhi: The government has tightened the export ban norms on anti-malarial drug hydroxychloroquine by including special economic zones (SEZs) under...
US begins stockpiling malaria medicine for treating COVID-19 patients Medical Dialogues Bureau1 April 2020 3:30 AMWashington: The US has started procuring malaria medicine 'Hydroxychloroquine' for treating COVID-19 patients as it anticipates a favorable result...
Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung Medical Dialogues Bureau30 March 2020 7:49 AMZurich: Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's...
Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research Medical Dialogues Bureau28 March 2020 7:22 AMThe trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare...
Hydroxychloroquine now a Prescription Drug: Health Ministry gazette puts it in Schedule H1 of DCA Medical Dialogues Bureau27 March 2020 7:37 AMNew Delhi: Soon after banning the export of the Drug Hydroxychloroquine in light of the coronavirus, the government has now made the Drug into a...
Novartis to donate up to 130 million doses of hydroxychloroquine for COVID-19 Medical Dialogues Bureau24 March 2020 4:30 AMBasel: Novartis has announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic...
